| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis, RNA | 11 | 2025 | 182 | 2.340 |
Why?
|
| Transcriptome | 13 | 2026 | 408 | 1.730 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2020 | 119 | 1.330 |
Why?
|
| Evolution, Molecular | 13 | 2018 | 351 | 1.320 |
Why?
|
| Genomics | 10 | 2020 | 386 | 1.130 |
Why?
|
| Genome, Human | 8 | 2019 | 238 | 1.010 |
Why?
|
| Fibroblasts | 3 | 2026 | 423 | 0.990 |
Why?
|
| Interferon Type I | 2 | 2026 | 198 | 0.960 |
Why?
|
| Photosensitivity Disorders | 1 | 2026 | 6 | 0.960 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2021 | 146 | 0.960 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2026 | 65 | 0.930 |
Why?
|
| Keratinocytes | 1 | 2026 | 76 | 0.920 |
Why?
|
| Myeloid Cells | 1 | 2026 | 98 | 0.900 |
Why?
|
| Sequence Analysis, DNA | 15 | 2019 | 417 | 0.880 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 689 | 0.870 |
Why?
|
| Software | 6 | 2020 | 401 | 0.830 |
Why?
|
| Islets of Langerhans | 4 | 2023 | 286 | 0.830 |
Why?
|
| Autoimmunity | 1 | 2026 | 250 | 0.820 |
Why?
|
| Single-Cell Analysis | 6 | 2025 | 119 | 0.820 |
Why?
|
| Dendritic Cells | 8 | 2020 | 534 | 0.780 |
Why?
|
| Gene Expression Profiling | 15 | 2026 | 799 | 0.770 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 171 | 0.740 |
Why?
|
| Fragile X Syndrome | 1 | 2022 | 29 | 0.700 |
Why?
|
| Skin | 4 | 2026 | 436 | 0.700 |
Why?
|
| Conserved Sequence | 8 | 2018 | 173 | 0.670 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 1635 | 0.650 |
Why?
|
| Animals | 45 | 2026 | 21489 | 0.640 |
Why?
|
| Mice | 30 | 2026 | 11185 | 0.630 |
Why?
|
| Bacteria | 4 | 2020 | 337 | 0.610 |
Why?
|
| Sequence Alignment | 7 | 2016 | 301 | 0.570 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2025 | 316 | 0.500 |
Why?
|
| Vitiligo | 3 | 2026 | 120 | 0.490 |
Why?
|
| Immunity, Innate | 3 | 2020 | 829 | 0.460 |
Why?
|
| Chromatin | 8 | 2021 | 643 | 0.450 |
Why?
|
| Ultraviolet Rays | 2 | 2026 | 153 | 0.440 |
Why?
|
| RNA, Untranslated | 6 | 2017 | 105 | 0.420 |
Why?
|
| Genetic Variation | 5 | 2018 | 395 | 0.390 |
Why?
|
| Cells, Cultured | 7 | 2026 | 2194 | 0.370 |
Why?
|
| Endothelial Cells | 2 | 2026 | 216 | 0.370 |
Why?
|
| Genome | 6 | 2018 | 286 | 0.360 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2026 | 282 | 0.360 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 80 | 0.350 |
Why?
|
| Organ Specificity | 3 | 2025 | 200 | 0.330 |
Why?
|
| Epigenesis, Genetic | 6 | 2021 | 408 | 0.330 |
Why?
|
| Herpesvirus 4, Human | 3 | 2018 | 199 | 0.320 |
Why?
|
| Humans | 48 | 2026 | 65826 | 0.310 |
Why?
|
| Base Sequence | 7 | 2017 | 1332 | 0.310 |
Why?
|
| T-Lymphocytes | 2 | 2026 | 1012 | 0.290 |
Why?
|
| Mammals | 4 | 2022 | 222 | 0.290 |
Why?
|
| DNA | 5 | 2021 | 853 | 0.260 |
Why?
|
| CRISPR-Cas Systems | 3 | 2017 | 369 | 0.260 |
Why?
|
| RNA | 5 | 2023 | 427 | 0.260 |
Why?
|
| Inflammation | 4 | 2026 | 1198 | 0.240 |
Why?
|
| Gene Library | 3 | 2016 | 102 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3504 | 0.240 |
Why?
|
| Dermatomyositis | 1 | 2026 | 11 | 0.240 |
Why?
|
| Transcription Factors | 7 | 2020 | 1561 | 0.240 |
Why?
|
| Computational Biology | 7 | 2018 | 369 | 0.240 |
Why?
|
| Gain of Function Mutation | 1 | 2026 | 20 | 0.230 |
Why?
|
| Epitope Mapping | 1 | 2026 | 52 | 0.230 |
Why?
|
| Female | 19 | 2026 | 34414 | 0.230 |
Why?
|
| Transcription, Genetic | 8 | 2014 | 910 | 0.230 |
Why?
|
| Mosaicism | 1 | 2025 | 29 | 0.230 |
Why?
|
| Algorithms | 2 | 2020 | 1060 | 0.230 |
Why?
|
| Seminal Vesicles | 1 | 2025 | 9 | 0.220 |
Why?
|
| RNA, Fungal | 2 | 2017 | 44 | 0.220 |
Why?
|
| Viral Matrix Proteins | 2 | 2016 | 50 | 0.220 |
Why?
|
| Rats | 4 | 2023 | 2005 | 0.220 |
Why?
|
| Dermatitis, Irritant | 1 | 2024 | 3 | 0.220 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2024 | 9 | 0.220 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2024 | 19 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2018 | 105 | 0.210 |
Why?
|
| CRISPR-Associated Proteins | 2 | 2015 | 32 | 0.210 |
Why?
|
| Toll-Like Receptors | 3 | 2018 | 434 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2026 | 185 | 0.210 |
Why?
|
| Ribosomal Proteins | 2 | 2012 | 42 | 0.200 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 160 | 0.200 |
Why?
|
| Spermatozoa | 2 | 2015 | 267 | 0.200 |
Why?
|
| Molecular Sequence Annotation | 4 | 2017 | 67 | 0.200 |
Why?
|
| Ribosomes | 2 | 2017 | 173 | 0.190 |
Why?
|
| Neutrophils | 1 | 2026 | 396 | 0.190 |
Why?
|
| Epididymis | 2 | 2020 | 26 | 0.190 |
Why?
|
| Chromosome Mapping | 3 | 2021 | 297 | 0.190 |
Why?
|
| Prediabetic State | 1 | 2023 | 54 | 0.180 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 72 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 1226 | 0.180 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 19 | 0.180 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2022 | 17 | 0.180 |
Why?
|
| HIV-1 | 2 | 2020 | 710 | 0.180 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2021 | 6 | 0.170 |
Why?
|
| RNA Interference | 1 | 2025 | 647 | 0.170 |
Why?
|
| Male | 18 | 2026 | 31398 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2017 | 1583 | 0.170 |
Why?
|
| Receptors, CCR5 | 1 | 2021 | 59 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 154 | 0.170 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 59 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 128 | 0.160 |
Why?
|
| Stochastic Processes | 1 | 2020 | 28 | 0.160 |
Why?
|
| Vas Deferens | 1 | 2020 | 5 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2017 | 573 | 0.160 |
Why?
|
| Synapses | 1 | 2022 | 195 | 0.160 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 17 | 0.160 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 8 | 0.160 |
Why?
|
| Goblet Cells | 1 | 2020 | 10 | 0.160 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2020 | 10 | 0.160 |
Why?
|
| Enterocytes | 1 | 2020 | 25 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 45 | 0.160 |
Why?
|
| Lung | 2 | 2022 | 969 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2026 | 926 | 0.150 |
Why?
|
| Endocrine Cells | 1 | 2019 | 10 | 0.150 |
Why?
|
| Viruses | 2 | 2011 | 82 | 0.150 |
Why?
|
| Mutation | 3 | 2025 | 2674 | 0.150 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2019 | 5 | 0.150 |
Why?
|
| Linear Models | 1 | 2020 | 405 | 0.150 |
Why?
|
| Adipocytes, Beige | 1 | 2019 | 15 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2019 | 16 | 0.150 |
Why?
|
| Adiponectin | 1 | 2019 | 37 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 223 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 679 | 0.150 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 60 | 0.150 |
Why?
|
| Exons | 4 | 2014 | 208 | 0.150 |
Why?
|
| Leptin | 1 | 2019 | 89 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2020 | 210 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 220 | 0.140 |
Why?
|
| DNA, Viral | 2 | 2016 | 232 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 143 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2019 | 128 | 0.140 |
Why?
|
| Caenorhabditis elegans | 1 | 2025 | 708 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2009 | 7 | 0.140 |
Why?
|
| tRNA Methyltransferases | 1 | 2017 | 10 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 2 | 2019 | 195 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 197 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 235 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 286 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 631 | 0.130 |
Why?
|
| Antigen Presentation | 1 | 2019 | 239 | 0.130 |
Why?
|
| Histones | 3 | 2021 | 497 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2019 | 326 | 0.130 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 1980 | 0.130 |
Why?
|
| Haplotypes | 5 | 2010 | 137 | 0.130 |
Why?
|
| Viral Load | 2 | 2016 | 230 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1391 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2021 | 3168 | 0.130 |
Why?
|
| Embryonic Stem Cells | 5 | 2021 | 154 | 0.130 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 32 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2022 | 2168 | 0.130 |
Why?
|
| Chromosomes | 1 | 2018 | 139 | 0.120 |
Why?
|
| Cell Nucleus | 2 | 2018 | 634 | 0.120 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 667 | 0.120 |
Why?
|
| Phylogeny | 6 | 2018 | 399 | 0.120 |
Why?
|
| Genome, Viral | 1 | 2018 | 145 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2017 | 91 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2017 | 93 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.120 |
Why?
|
| Infectious Mononucleosis | 1 | 2016 | 34 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2017 | 127 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 196 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 29 | 0.120 |
Why?
|
| Microfluidics | 1 | 2016 | 26 | 0.120 |
Why?
|
| Ebolavirus | 1 | 2016 | 39 | 0.120 |
Why?
|
| Neurons | 1 | 2022 | 935 | 0.120 |
Why?
|
| RNA-Binding Proteins | 3 | 2013 | 446 | 0.120 |
Why?
|
| RNA, Transfer, Gly | 1 | 2015 | 5 | 0.120 |
Why?
|
| Viral Envelope Proteins | 1 | 2016 | 102 | 0.120 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 31 | 0.120 |
Why?
|
| DNA, Intergenic | 3 | 2010 | 24 | 0.120 |
Why?
|
| Sperm Maturation | 1 | 2015 | 9 | 0.120 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2017 | 451 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 964 | 0.120 |
Why?
|
| Thermus thermophilus | 1 | 1995 | 20 | 0.110 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2015 | 77 | 0.110 |
Why?
|
| Fertilization | 1 | 2015 | 83 | 0.110 |
Why?
|
| Models, Biological | 1 | 2020 | 1193 | 0.110 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.110 |
Why?
|
| HIV Infections | 3 | 2020 | 961 | 0.110 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 115 | 0.110 |
Why?
|
| Caspase 9 | 1 | 2015 | 21 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 22 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 220 | 0.110 |
Why?
|
| Histone Demethylases | 1 | 2015 | 30 | 0.110 |
Why?
|
| Fetus | 1 | 2015 | 103 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 565 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2014 | 43 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 329 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 472 | 0.110 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 100 | 0.110 |
Why?
|
| Cluster Analysis | 4 | 2021 | 267 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2014 | 33 | 0.100 |
Why?
|
| Proviruses | 1 | 2014 | 27 | 0.100 |
Why?
|
| Oropharynx | 1 | 2014 | 12 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 77 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 76 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 663 | 0.100 |
Why?
|
| HEK293 Cells | 4 | 2019 | 617 | 0.100 |
Why?
|
| Cell Line | 3 | 2020 | 2031 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2014 | 165 | 0.100 |
Why?
|
| Endonucleases | 1 | 2014 | 84 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 320 | 0.100 |
Why?
|
| Selection, Genetic | 2 | 2011 | 90 | 0.100 |
Why?
|
| Synteny | 6 | 2009 | 24 | 0.090 |
Why?
|
| Escherichia coli Proteins | 1 | 1995 | 278 | 0.090 |
Why?
|
| RNA Stability | 1 | 2013 | 104 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 563 | 0.090 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 333 | 0.090 |
Why?
|
| RNA Polymerase II | 3 | 2021 | 86 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 741 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2010 | 267 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 269 | 0.080 |
Why?
|
| Adult | 7 | 2026 | 17567 | 0.080 |
Why?
|
| Cellular Reprogramming | 1 | 2010 | 41 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2008 | 518 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2011 | 142 | 0.080 |
Why?
|
| Lipopolysaccharides | 3 | 2026 | 625 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 33 | 0.080 |
Why?
|
| Horses | 1 | 2009 | 53 | 0.080 |
Why?
|
| Liver | 1 | 2014 | 875 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2018 | 84 | 0.070 |
Why?
|
| Gene Duplication | 2 | 2006 | 35 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 365 | 0.070 |
Why?
|
| Melanoma | 1 | 2013 | 335 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 160 | 0.070 |
Why?
|
| Neoplasms | 1 | 2019 | 1377 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2026 | 1146 | 0.070 |
Why?
|
| Dogs | 2 | 2009 | 326 | 0.070 |
Why?
|
| Epigenomics | 2 | 2021 | 62 | 0.070 |
Why?
|
| Zebrafish | 1 | 2011 | 374 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 314 | 0.070 |
Why?
|
| Phenotype | 2 | 2025 | 1236 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 411 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1589 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 223 | 0.070 |
Why?
|
| Opossums | 1 | 2007 | 3 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2009 | 351 | 0.060 |
Why?
|
| Middle Aged | 5 | 2026 | 18491 | 0.060 |
Why?
|
| Retroelements | 2 | 2017 | 44 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 24 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 33 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 7 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 676 | 0.060 |
Why?
|
| Eukaryota | 2 | 2018 | 31 | 0.060 |
Why?
|
| Clone Cells | 1 | 2025 | 111 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 377 | 0.060 |
Why?
|
| RNA, Ribosomal | 2 | 2017 | 60 | 0.050 |
Why?
|
| Semen | 1 | 2025 | 50 | 0.050 |
Why?
|
| Apoptosis | 2 | 2026 | 1100 | 0.050 |
Why?
|
| Young Adult | 4 | 2019 | 4878 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 1720 | 0.050 |
Why?
|
| Drug Eruptions | 1 | 2024 | 17 | 0.050 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2024 | 11 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2024 | 147 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 151 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2009 | 517 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2020 | 263 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2016 | 283 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 169 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 199 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1172 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2023 | 106 | 0.050 |
Why?
|
| Genes | 3 | 2009 | 90 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 709 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2024 | 576 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 299 | 0.050 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 59 | 0.050 |
Why?
|
| Odorants | 1 | 2022 | 19 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 83 | 0.040 |
Why?
|
| Smell | 1 | 2022 | 29 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 20 | 0.040 |
Why?
|
| Histone Code | 1 | 2021 | 25 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 995 | 0.040 |
Why?
|
| Adolescent | 3 | 2020 | 6367 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2014 | 282 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 34 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2022 | 229 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 206 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 291 | 0.040 |
Why?
|
| Programming Languages | 1 | 2020 | 13 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2025 | 448 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2021 | 210 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2020 | 73 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2010 | 117 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 436 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2020 | 127 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 125 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2022 | 439 | 0.040 |
Why?
|
| Aging | 1 | 2025 | 784 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 241 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 87 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 491 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 755 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 2088 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2019 | 179 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 206 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1502 | 0.040 |
Why?
|
| Graft Survival | 1 | 2019 | 300 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 1637 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 2329 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 126 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 541 | 0.030 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 13 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2020 | 284 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2012 | 1160 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 40 | 0.030 |
Why?
|
| Child | 2 | 2020 | 4653 | 0.030 |
Why?
|
| 5' Flanking Region | 1 | 2017 | 10 | 0.030 |
Why?
|
| 3' Flanking Region | 1 | 2017 | 8 | 0.030 |
Why?
|
| Exonucleases | 1 | 2017 | 6 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2018 | 71 | 0.030 |
Why?
|
| Ribonuclease H | 1 | 2017 | 19 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2020 | 213 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 130 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 357 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 383 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.030 |
Why?
|
| Genes, Insect | 1 | 2017 | 98 | 0.030 |
Why?
|
| Convalescence | 1 | 2016 | 17 | 0.030 |
Why?
|
| Africa, Western | 1 | 2016 | 5 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.030 |
Why?
|
| Cheirogaleidae | 1 | 2016 | 6 | 0.030 |
Why?
|
| Base Composition | 2 | 2007 | 30 | 0.030 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2016 | 22 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 3778 | 0.030 |
Why?
|
| Callithrix | 1 | 2016 | 21 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 80 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 888 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2020 | 314 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 588 | 0.030 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2006 | 4 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 199 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 2015 | 12 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 238 | 0.030 |
Why?
|
| Virion | 1 | 2016 | 122 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 696 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2015 | 17 | 0.030 |
Why?
|
| Multigene Family | 2 | 2006 | 106 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 424 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2016 | 257 | 0.030 |
Why?
|
| Crystallization | 1 | 1995 | 97 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 74 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2015 | 105 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 37 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 692 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 664 | 0.030 |
Why?
|
| Testis | 1 | 2015 | 160 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 386 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 129 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 362 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 2015 | 76 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 345 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 257 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 279 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 414 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 11 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 94 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 20 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 700 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2015 | 306 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 3339 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 745 | 0.020 |
Why?
|
| Exoribonucleases | 1 | 2013 | 30 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2013 | 56 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 248 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 312 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 181 | 0.020 |
Why?
|
| Semiconductors | 1 | 2013 | 14 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 22 | 0.020 |
Why?
|
| Archaea | 1 | 2012 | 10 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1573 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2016 | 719 | 0.020 |
Why?
|
| Diet | 1 | 2015 | 540 | 0.020 |
Why?
|
| Health | 1 | 2011 | 30 | 0.020 |
Why?
|
| Disease | 1 | 2011 | 26 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 762 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 98 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 36 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 74 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2014 | 415 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 1 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 120 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 717 | 0.020 |
Why?
|
| Population Groups | 1 | 2010 | 14 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2009 | 15 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 15 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 921 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 45 | 0.020 |
Why?
|
| Poly I-C | 1 | 2009 | 76 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 42 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2009 | 73 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1441 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 85 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2009 | 51 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 793 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 103 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 714 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1720 | 0.020 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2009 | 148 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 109 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 855 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 297 | 0.020 |
Why?
|
| Diploidy | 1 | 2008 | 11 | 0.020 |
Why?
|
| Haploidy | 1 | 2008 | 13 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2402 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2649 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 79 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 238 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 61 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 514 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2006 | 18 | 0.010 |
Why?
|
| Defensins | 1 | 2006 | 4 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2006 | 3 | 0.010 |
Why?
|
| Euchromatin | 1 | 2006 | 16 | 0.010 |
Why?
|
| Obesity | 1 | 2014 | 1279 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 2006 | 24 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 160 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 28 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 2005 | 31 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 133 | 0.010 |
Why?
|
| Dog Diseases | 1 | 2005 | 47 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2005 | 42 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 114 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 1229 | 0.010 |
Why?
|
| CpG Islands | 1 | 2005 | 219 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5830 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 5681 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 15141 | 0.010 |
Why?
|